[HTML][HTML] Intensive lipid lowering with atorvastatin in patients with stable coronary disease

JC LaRosa, SM Grundy, DD Waters… - … England Journal of …, 2005 - Mass Medical Soc
Background Previous trials have demonstrated that lowering low-density lipoprotein (LDL)
cholesterol levels below currently recommended levels is beneficial in patients with acute …

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

Developed in Collaboration With the European … - Journal of the American …, 2006 - jacc.org
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: A Report of the American College of …

[图书][B] Rose's strategy of preventive medicine: the complete original text

GA Rose, KT Khaw, M Marmot - 2008 - books.google.com
The Strategy of Preventive Medicine by Geoffrey Rose, first published in 1993, remains a
key text for anyone involved in preventive medicine. Rose's insights into the inextricable …

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and …

I Graham, D Atar, K Borch-Johnsen… - European heart …, 2007 - academic.oup.com
†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

Family health behaviors

I Fadlon, TH Nielsen - American Economic Review, 2019 - aeaweb.org
We study how health behaviors are shaped through family spillovers. We leverage
administrative data to identify the effects of health shocks on family members' consumption …

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

PM Ridker, E Danielson, FAH Fonseca, J Genest… - The Lancet, 2009 - thelancet.com
Background Statins lower high-sensitivity C-reactive protein (hsCRP) and cholesterol
concentrations, and hypothesis generating analyses suggest that clinical outcomes improve …

Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence

S Lorente-Cebrián, AGV Costa… - Journal of physiology …, 2013 - Springer
The present review aims to illustrate current knowledge about the efficacy of omega-3 long-
chain polyunsaturated fatty acids (n− 3 LC-PUFAs) in treating/preventing several metabolic …

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

K Kotseva, D Wood, GD Backer… - European Journal of …, 2009 - academic.oup.com
Aim The aim of the European Action on Secondary and Primary Prevention by Intervention
to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European …

One-year cardiovascular event rates in outpatients with atherothrombosis

PG Steg, DL Bhatt, PWF Wilson, R D'Agostino… - Jama, 2007 - jamanetwork.com
ContextFew data document current cardiovascular (CV) event rates in stable patients with
atherothrombosis in a community setting. Differential event rates for patients with …

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

M Schachter - Fundamental & clinical pharmacology, 2005 - Wiley Online Library
Statins are the treatment of choice for the management of hypercholesterolaemia because of
their proven efficacy and safety profile. They also have an increasing role in managing …